Catalyst Wire Dossier Catalyst Wire Dossier

Lenalidomide Dexamethasone with Elotuzumab

· Bristol-Myers Squibb
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lenalidomide Dexamethasone with Elotuzumab, covering 2018-03-22 to 2018-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan [Phase 2]

See pricing